Dicot has started manufacturing of the study drug for clinical trials in line with the schedule
Press release: Uppsala, February 20, 2023. Dicot announces that the GMP manufacturing of the study drug for the planned phase 1 studies has begun. This is completely in line with the company's time schedule for start of clinical studies. The manufacture refers to both study drugs with active substance and placebo.Dicot has previously announced that Thermo Fischer Scientific has been contracted for GMP (Good Manufacturing Practice) manufacturing of the study drug for the company's phase 1 studies. Today, Dicot announces that production has started. This is completely in line with the overall